Cancer Family
Malignant Digestive System Neoplasm
CI-CAN-00000229Explore in graph →
4,262 active trials43 approved drugs556 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000229Explore in graph →
Clinical trials
19,101 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (2,000)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07796334 | Colon Health Champion Program | not yet recruiting | N/A | 29 | Virginia Commonwealth UniversityOTHER | 1 | Sep 1, 2026 | clinicaltrials |
| NCT07796997 | GI-06: The Impact of Perioperative Hydrocortisone on Patients Undergoing Partial Pancreatectomy | not yet recruiting | Phase 1 | 20 | University of Illinois at ChicagoOTHER | 1 | Sep 1, 2026 | clinicaltrials |
| NCT07736612 |
| A Pan-RAS Inhibitor in Combination With Anti-Tumor Therapy in Participants With Advanced Pancreatic Cancer |
| not yet recruiting |
| Phase 1 / Phase 2 |
| 80 |
| Zhejiang UniversityOTHER |
| 1 |
| Aug 31, 2026 |
| clinicaltrials |
| NCT07794969 | Pancreatic Cancer Lifestyle Evolution And Resistance(CLEAR) | not yet recruiting | — | 150 | IRCCS San RaffaeleOTHER | 0 | Aug 31, 2026 | clinicaltrials |
| NCT07632235 | A Multicenter, Prospective, Randomized, Open-label Phase Ib/II Study of Celecoxib Plus Pembrolizumab and Gemcitabine/Cisplatin Versus Pembrolizumab and Gemcitabine/Cisplatin in Patients With CK5/6-High Unresectable Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma | not yet recruiting | Phase 1 / Phase 2 | 112 | Shanghai 6th People's HospitalOTHER | 1 | Aug 28, 2026 | clinicaltrials |
| NCT07669727 | A Post Approval Study to Evaluate Safety and Effectiveness of Multicompartmental Dosimetry Planning.(ADVANCE-MCD) | not yet recruiting | — | 140 | Boston Scientific CorporationINDUSTRY | 0 | Aug 28, 2026 | clinicaltrials |
| NCT07768358 | Tucatinib Continuation Study | not yet recruiting | Phase 4 | 175 | PfizerINDUSTRY | 0 | Aug 28, 2026 | clinicaltrials |
| NCT07780357 | HCC Risk Prediction Model Based on Multimodal Data in Chronic Hepatitis B | not yet recruiting | — | 2,000 | Beijing Friendship HospitalOTHER | 1 | Aug 28, 2026 | clinicaltrials |
| NCT07781852 | Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer | not yet recruiting | Early Phase 1 | 40 | Lumina Pharmaceuticals IncINDUSTRY | 1 | Aug 28, 2026 | clinicaltrials |
| NCT07791550 | Baduanjin for Quality of Life in Pancreatic Cancer Chemotherapy(BDJ-PC) | not yet recruiting | N/A | 96 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Aug 28, 2026 | clinicaltrials |
| NCT07791979 | High-Flow Nasal Cannula Oxygenation During Sedated Gastrointestinal Endoscopy in Patients With Chronic Obstructive Pulmonary Disease | not yet recruiting | N/A | 90 | Zhejiang UniversityOTHER | 1 | Aug 28, 2026 | clinicaltrials |
| NCT07792109 | Implementation Of A Telesurgery Program At A Referral Center For Robotic Surgery(GTSP) | not yet recruiting | N/A | 25 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Aug 28, 2026 | clinicaltrials |
| NCT07793253 | Phase 2 Study of Daraxonrasib in Recurrent KRAS-Mutant Biliary Tract Cancer | not yet recruiting | Phase 2 | 55 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 28, 2026 | clinicaltrials |
| NCT07224022 | Cemiplimab With Fianlimab for Resectable Non-Metastatic Colon Cancer(NACho) | not yet recruiting | Phase 2 | 24 | John Strickler, M.D.OTHER | 0 | Aug 27, 2026 | clinicaltrials |
| NCT07730489 | A Study Comparing BL-M07D1 With Physician's Choice Therapy in Patients With HER2 IHC3+ Advanced Colorectal Cancer Who Failed Prior Treatment With Oxaliplatin, Fluorouracil and Irinotecan | not yet recruiting | Phase 3 | 130 | Sichuan Baili Pharmaceutical Co., Ltd.INDUSTRY | 1 | Aug 27, 2026 | clinicaltrials |
| NCT07753824 | A Phase II Study of Ivonescimab Combined With Intraperitoneal Paclitaxel in Patients With High-Grade Metastatic Appendiceal Adenocarcinoma (AA) | not yet recruiting | Phase 2 | 30 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 27, 2026 | clinicaltrials |
| NCT07789184 | Radical Surgery Versus Non-Surgery in Gastric Cancer Patients With Peritoneal Metastasis After Successful Conversion Therapy | not yet recruiting | Phase 3 | 170 | Hua Huang, MD, PhDOTHER | 1 | Aug 27, 2026 | clinicaltrials |
| NCT07790601 | Swabs in Screening for HPV (SWISH)(SWISH) | not yet recruiting | N/A | 700 | Kirby InstituteOTHER_GOV | 1 | Aug 27, 2026 | clinicaltrials |
| NCT06656936 | The PharmFIT Study(PharmFIT) | not yet recruiting | N/A | 1,500 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Aug 26, 2026 | clinicaltrials |
| NCT07341126 | Use of a Novel Camera to Check the Bowel After Polyp or Tumour Removal(R-ALERT) | not yet recruiting | — | 30 | University of EdinburghOTHER | 1 | Aug 26, 2026 | clinicaltrials |
| NCT07494994 | SURGIMEDIA: Utilization of Multimedia for Enhanced Surgical Consent(SURGIMEDIA) | not yet recruiting | N/A | 60 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Aug 26, 2026 | clinicaltrials |
| NCT07551778 | Allogeneic NK Cell Therapy Combined With Standard Maintenance Treatment in Advanced Solid Tumors | not yet recruiting | Phase 1 / Phase 2 | 42 | BOE Technology Group Co., Ltd.INDUSTRY | 0 | Aug 26, 2026 | clinicaltrials |
| NCT07787156 | Reach and Engagement of GENetic Education, Risk Assessment, and TEsting Feasibility Trial(REGENERATE) | not yet recruiting | N/A | 80 | Brigham and Women's HospitalOTHER | 1 | Aug 26, 2026 | clinicaltrials |
| NCT07788001 | A Non-inferiority Study of Indocyanine Green-guided Sentinel Lymph Node Mapping Versus Conventional Lymph Node Dissection in Esophageal Cancer(SIGN) | not yet recruiting | Phase 3 | 200 | Fujian Medical University Union HospitalOTHER | 1 | Aug 26, 2026 | clinicaltrials |
| NCT07788664 | Local and Systemic Immune Modulation by Rilvegostomig (AZD2936) in the Treatment of Advanced Gastric Cancer (RILVE Project)(RILVE) | not yet recruiting | Phase 2 | 50 | Vall d'Hebron Institute of OncologyOTHER | 1 | Aug 26, 2026 | clinicaltrials |
| NCT07780968 | Zanidatamab Outcomes and Lived Experiences in Advanced HER2+ GEA(ZOLA) | not yet recruiting | — | 300 | Jazz PharmaceuticalsINDUSTRY | 1 | Aug 25, 2026 | clinicaltrials |
| NCT07784374 | A Phase II Study of GFH375 Combined With GFS202A or GFH276 Versus GFH375 Monotherapy in Patients With Previously Treated Locally Advanced Unresectable or Metastatic Pancreatic Cancer Harboring KRAS G12D Mutation | not yet recruiting | Phase 2 | 120 | Genfleet Therapeutics (Shanghai) Inc.INDUSTRY | 1 | Aug 25, 2026 | clinicaltrials |
| NCT07781176 | Different Acupoint Stimulation for Postoperative Gastrointestinal Dysfunction in Primary Liver Cancer Patients | not yet recruiting | N/A | 132 | Shanghai Zhongshan HospitalOTHER | 0 | Aug 24, 2026 | clinicaltrials |
| NCT07781774 | Improving Colorectal Cancer Screening Uptake Through Education and Stool-Based Testing Outreach | not yet recruiting | N/A | 200 | Washington University School of MedicineOTHER | 1 | Aug 24, 2026 | clinicaltrials |
| NCT07782294 | AI-Assisted Novel rbcDNA Detection for Early Gastric Cancer Diagnosis | not yet recruiting | — | 542 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Aug 24, 2026 | clinicaltrials |
| NCT07581405 | GI-05: The Impact of Olanzapine Among Patients Receiving Neoadjuvant Chemotherapy for Gastric Cancer | not yet recruiting | Phase 2 | 26 | University of Illinois at ChicagoOTHER | 1 | Aug 21, 2026 | clinicaltrials |
| NCT07778056 | Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Immunochemotherapy for Resectable Esophageal Cancer: A Target Trial Emulation Study(TTE-ESCC) | not yet recruiting | — | 400 | Henan Cancer HospitalOTHER_GOV | 0 | Aug 21, 2026 | clinicaltrials |
| NCT07780721 | Study of Adebrelimab Combined With Thymalfasin and Chemotherapy for Neoadjuvant Treatment of Esophageal Cancer | not yet recruiting | Phase 2 | 31 | The Affiliated Hospital of Putian UniversityOTHER | 1 | Aug 21, 2026 | clinicaltrials |
| NCT07608458 | Scheduled Meditation for Improving Postoperative Outcomes in Patients Undergoing Pancreatectomy | not yet recruiting | N/A | 70 | City of Hope Medical CenterOTHER | 1 | Aug 20, 2026 | clinicaltrials |
| NCT07770100 | Concurrent Immunotherapy and Systemic Therapy With Stereotactic Body Radiation Therapy (SBRT) for Stage IV Cancers (COINSSS IV) | not yet recruiting | Phase 2 | 35 | Mark BernardOTHER | 1 | Aug 20, 2026 | clinicaltrials |
| NCT07775859 | NOMAD-GI: Molecular-guided Non-operative Management and Organ Preservation Strategy After Precision Therapy in Gastrointestinal Cancers(NOMAD-GI) | not yet recruiting | — | 200 | Peking University Cancer Hospital & InstituteOTHER | 0 | Aug 20, 2026 | clinicaltrials |
| NCT07175389 | JDB153 Combined With Serplulimab for Pancreatic Cancer After Standard Treatment Failure | not yet recruiting | Phase 1 / Phase 2 | 10 | West China HospitalOTHER | 1 | Aug 19, 2026 | clinicaltrials |
| NCT07772258 | Wearable-Supported Prehabilitation and Rehabilitation for Patients Undergoing Surgery for Pancreatic Cancer(POWR-PaC) | not yet recruiting | N/A | 120 | Manchester University NHS Foundation TrustOTHER_GOV | 0 | Aug 19, 2026 | clinicaltrials |
| NCT07772453 | Ferric Carboxymaltose Versus Iron Sucrose for Iron Deficiency Anemia After Radical Gastrectomy for Gastric Cancer(IRIS) | not yet recruiting | Phase 4 | 160 | Zhaojian Niu,MDOTHER | 0 | Aug 19, 2026 | clinicaltrials |
| NCT07773363 | Retlirafusp Alfa Plus Apatinib and Chemotherapy as Second-Line Treatment for Pancreatic Cancer | not yet recruiting | Phase 2 | 37 | Tang-Du HospitalOTHER | 0 | Aug 19, 2026 | clinicaltrials |
| NCT07774247 | Atezolizumab, Bevacizumab, and Tocilizumab in Advanced Hepatocellular Carcinoma(AB-TCZ) | not yet recruiting | Phase 2 | 51 | CHA UniversityOTHER | 1 | Aug 19, 2026 | clinicaltrials |
| NCT07774754 | Radiotherapy Combined With Capeox Chemotherapy, Sintilimab and Suvemcitug in Locally Advanced pMMR Rectal Cancer:a Prospective Clinical Trial(RADIANT) | not yet recruiting | Phase 2 | 18 | Sun Yat-sen UniversityOTHER | 1 | Aug 19, 2026 | clinicaltrials |
| NCT07219745 | Transanal Irrigation for the Management of Early Low Anterior Resection Syndrome (LARS) | not yet recruiting | N/A | 60 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 18, 2026 | clinicaltrials |
| NCT07769658 | Standardized MRI and Structured Reporting for Esophageal Squamous Cell Carcinoma(ESCC-MRI-TRG) | not yet recruiting | — | 500 | The First Affiliated Hospital of Zhengzhou UniversityOTHER | 1 | Aug 18, 2026 | clinicaltrials |
| NCT07769866 | Retlirafusp Alfa Combined With Chemoradiotherapy in Unresectable ESCC | not yet recruiting | N/A | 68 | RenJi HospitalOTHER | 1 | Aug 18, 2026 | clinicaltrials |
| NCT07767994 | AK112 Combined With GAP Conversion Therapy for Locally Advanced Gallbladder Cancer(ICORE-GBC) | not yet recruiting | Phase 2 | 22 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 0 | Aug 17, 2026 | clinicaltrials |
| NCT07768085 | Pragmatic RCT of AI-Assisted Reading for Malignant Hepatic Lesions on CE-CT | not yet recruiting | N/A | 40,000 | Shengjing HospitalOTHER | 1 | Aug 17, 2026 | clinicaltrials |
| NCT05038098 | Magnetic Sentinel Lymph Node Mapping in Gastric Cancer | not yet recruiting | Phase 1 | 20 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 14, 2026 | clinicaltrials |
Data updated 22 days agoSource updated Sep 1, 2026source: clinicaltrials